论文部分内容阅读
目的:探讨卡孕栓联合缩宫素预防产后出血效果。方法:将2015年1月-2016年1月我院收治的146例顺产产妇随机分为两组,即对照组和研究组,研究组产妇在胎儿娩出后使用卡孕栓联合催产素治疗,对照组产妇采用催产素治疗,记录并比较两组产妇产程中、产后2h及产后24h的出血量,并比较两组患者的不良反应发生情况。结果:研究组患者在产后出血量、2h出血量和24h出血量均显著少于对照组(P<0.05),具有统计学差异。两组患者的不良反应主要有皮肤瘙痒、胃肠道反应和面色潮红等,两组患者在不良反应发生率上无显著差异(P>0.05),所有患者无严重不良反应。结论:卡孕栓联合宫缩素预防产后出血的临床疗效显著,值得临床推广应用。
Objective: To investigate the effect of carbamazole combined with oxytocin in preventing postpartum hemorrhage. Methods: 146 cases of primiparous women admitted to our hospital from January 2015 to January 2016 were randomly divided into two groups: the control group and the study group. The study group was treated with carboplatin and oxytocin after the fetus was delivered, while the control group Group of maternal oxytocin treatment, record and compare the two groups of labor, 2h postpartum and 24h postpartum bleeding, and compare the two groups of patients with adverse reactions. Results: The study group had significantly less postpartum hemorrhage, 2h haemorrhage and 24 h haemorrhage than the control group (P <0.05). The two groups of patients with adverse reactions are mainly skin itching, gastrointestinal reactions and flushing, two groups of patients in the incidence of adverse reactions no significant difference (P> 0.05), all patients without serious adverse reactions. Conclusion: The curative effect of catarrhaphy suppository and epididyol in preventing postpartum hemorrhage is significant, which is worthy of clinical application.